ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast of Editas Medicine Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Editas Medicine EDIT at this time. Stock is rising and might rise more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!

My analysis of Editas Medicine is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Editas Medicine stays above 2.5, but if it comes below 2.5, then a intra day sell could be more profitable.
If you take a sell trade below 2.5, then use 2.5 as stoploss and 2.19 as target. However if you take a buy trade in Editas Medicine, then use 2.5 as stoploss and 2.8 as target.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

Exporters seek 6-month loan moratorium, higher credit as ?billion West Asia trade faces disruption West Asia conflict: Indian exporters are requesting a six-month loan repayment pause and increased credit from the government and Reserve Bank of India. This is to counter disruptions in shipments to West Asia, a major trade partner. Policymakers are consi - NEWS as on 2026-03-17 indiatimes.com

US Stocks: Private credit strains ripple through Wall Street as investors grow wary Private-credit market jitters have spilled onto Wall Street, with some major U.S. banks tightening lending while the funds have capped withdrawals as mounting concerns prompt firms to curb risk ?and brace for further strain. - NEWS as on 2026-03-16 indiatimes.com

Global Market | S&P warns oil spike from Middle East war could test global credit stability S&P Global Ratings said it will avoid immediate sovereign downgrades despite the escalating Middle East conflict, but warned that higher oil and gas prices could strain vulnerable economies. Energy-import-dependent Asian countries and debt-laden South - NEWS as on 2026-03-13 indiatimes.com

India’s private credit market well insulated from global turbulence: Rakshat Kapoor Recent stress in global private credit markets is seen as isolated to a few developed market funds, not posing a systemic threat. India's private credit market, still in its early stages with tight covenants, minimal leverage, and closed-ended structures, - NEWS as on 2026-03-12 indiatimes.com

Impact on credit culture: One good deed could sow seeds for many bad loans The Maharashtra government fulfilled its poll promise waiving loans up to Rs 2 lakh and also offering a Rs 50,000 incentive for farmers regularly paying their loans. The government has earmarked Rs 20,000 crore for the waiver and Rs 15,000 crore for the in - NEWS as on 2026-03-10 indiatimes.com

What is the fastest growing thing in finance? SIPs? SIFs? Credit cards? Radhika Gupta answers Women are emerging as the fastest-growing segment in India’s financial ecosystem, according to Edelweiss Mutual Fund CEO Radhika Gupta. Participation by women has surged across mutual funds, equities, insurance and digital payments, reflecting a broader sh - NEWS as on 2026-03-07 indiatimes.com

Retail-sales and consumer-credit data join jobs report on Friday’s calendar - NEWS as on 2026-03-06 marketwatch.com

Is There Opportunity in Private Credit Stocks or Still Too Much Risk? Investing in the private credit market can offer high yields, but the downside risks are real and increasingly visible. - NEWS as on 2026-03-05 nasdaq.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 2.5
  • 12Day Average: 2.26
  • 20Day Average: 2.11
  • 50Day Average: 2.05
  • 100Day Average: 2.33
  • 150Day Average: 2.59
  • 200Day Average: 2.55

EDIT Indicators & signals

Indicator MACD (12,26,9)

2.29, 2.16, 0.08
Indicator MACD is in positive zone

Indicator ADX (14)

12.5, 39.13, 30.43
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 58
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Mon Mar 2026 2.54 2.45 to 2.59 4.1% 0.63 times
13 Fri Mar 2026 2.44 2.41 to 2.64 -3.94% 0.63 times
12 Thu Mar 2026 2.54 2.46 to 2.64 -4.87% 0.78 times
11 Wed Mar 2026 2.67 2.41 to 2.79 15.09% 0.86 times
09 Mon Mar 2026 2.32 1.93 to 2.47 15.42% 2.27 times
06 Fri Mar 2026 2.01 1.82 to 2.04 5.79% 1.06 times
05 Thu Mar 2026 1.90 1.89 to 2.18 -13.24% 0.94 times
04 Wed Mar 2026 2.19 2.03 to 2.28 7.35% 1.09 times
03 Tue Mar 2026 2.04 1.97 to 2.10 -5.12% 0.81 times
02 Mon Mar 2026 2.15 2.07 to 2.20 -2.27% 0.54 times
27 Fri Feb 2026 2.20 2.11 to 2.29 1.38% 1 times
26 Thu Feb 2026 2.17 2.05 to 2.22 1.88% 0.99 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top